Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Noxopharm Ltd. ( (AU:NOX) ) is now available.
Noxopharm Limited has issued 1,250,000 convertible notes and 250,000 unlisted options to 4F Investments Pty Limited, associated with a company director. This financial maneuver, involving a conversion of an unsecured loan into convertible notes, will not bring new cash inflow but will impact the company’s capital structure by potentially increasing the number of shares if the notes are converted. The move is designed to allow the resale of shares without disclosure to retail investors, potentially diluting existing shareholdings and altering the company’s equity distribution.
More about Noxopharm Ltd.
Noxopharm Limited operates in the pharmaceutical industry, focusing on developing innovative oncology drugs. The company is engaged in creating therapies that target cancer treatment, aiming to improve patient outcomes in the oncology market.
Average Trading Volume: 82,642
Technical Sentiment Signal: Buy
Current Market Cap: A$28.93M
See more data about NOX stock on TipRanks’ Stock Analysis page.